Few important updates in the Q4 report
Several interesting read-outs coming up in 2020
Current cash positon should fund operation well into 2021
Triggers: New studies, read-out mesothelioma and melanoma trials
11 Mar 2020
Still waiting for the convincing news
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Still waiting for the convincing news
Few important updates in the Q4 report
Several interesting read-outs coming up in 2020
Current cash positon should fund operation well into 2021
Triggers: New studies, read-out mesothelioma and melanoma trials